Form 4: Sylvamo Corp. COO John V. Sims Granted Restricted Stock Units
Insider Transaction Report
Sylvamo Corp.'s SVP & Chief Operating Officer, John V. Sims, was granted 505 time-based restricted stock units, vesting over three years, as part of his compensation.
Summary
- John V. Sims, the Senior Vice President and Chief Operating Officer of Sylvamo Corp. (SLVM), acquired 505 shares of common stock.
- These shares are in the form of time-based Restricted Stock Units (RSUs), granted at a price of $0.00 per share.
- The grant date for these RSUs was June 1, 2025.
- The RSUs will vest in three equal installments: one-third on March 1, 2026, one-third on March 1, 2027, and the final one-third on March 1, 2028, contingent upon Mr. Sims' continued service.
- Following this transaction, John V. Sims' beneficial ownership in Sylvamo Corp. stands at 90,180.6003 shares of common stock.
Sentiment
Score: 7
Explanation: The grant of restricted stock units to a key executive is generally viewed positively as it aligns management's long-term interests with those of shareholders, promoting retention and performance. It is a standard compensation practice.
Positives
- The grant of restricted stock units to a key executive like John V. Sims aligns management's long-term interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
- This type of equity compensation serves as a retention mechanism, encouraging continued service from a senior officer.
Risks
- The vesting of the restricted stock units is subject to the reporting person's continued service, meaning the executive would forfeit unvested units if employment ceases before the vesting dates.
Future Outlook
The grant of restricted stock units to a key executive indicates a long-term commitment and aligns management's interests with future company performance, with vesting scheduled through March 2028, contingent on continued service.
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction, specifically an equity compensation grant to a senior executive. Such grants are common practice across various industries to incentivize and retain key management personnel, aligning their financial interests with the long-term success of the company.
Related Party Transactions
- The acquisition of 505 restricted stock units by John V. Sims, a Senior Vice President and Chief Operating Officer, from Sylvamo Corp. represents a standard compensation-related related party transaction between the company and an executive.
Stakeholder Impact
- Shareholders: The grant of RSUs aligns the interests of a key executive with those of shareholders, potentially leading to better long-term performance and value creation.
- Employees (specifically John V. Sims): The executive receives equity compensation, incentivizing continued service and performance.
Next Steps
- Vesting of one-third of the granted RSUs on March 1, 2026, subject to continued service.
- Vesting of one-third of the granted RSUs on March 1, 2027, subject to continued service.
- Vesting of the final one-third of the granted RSUs on March 1, 2028, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 06/01/2025 | Date of the RSU grant to John V. Sims. |
| 06/03/2025 | Date the Form 4 filing was signed. |
| 03/01/2026 | First vesting date for one-third of the granted RSUs. |
| 03/01/2027 | Second vesting date for one-third of the granted RSUs. |
| 03/01/2028 | Third and final vesting date for one-third of the granted RSUs. |
Keywords
Sylvamo Corp, SLVM, Form 4, insider transaction, restricted stock units, RSU, executive compensation, beneficial ownership, John V. Sims
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.